Advertisement
Conference Call Details
To access the live conference call via phone, please dial (877) 356-8064from the United States and Canada or (706) 758-4314 internationally. Theconference ID is 33305336. Please dial in approximately ten minutes prior tothe start of the call. A telephone replay will be available beginningapproximately one hour after the call through February 12 and may be accessedby dialing (800) 642-1687 from the United States and Canada or (706) 645-9291internationally. The replay passcode is 33305336.
Advertisement
To access the live and subsequently archived webcast of the conferencecall, go to the Investor Relations section of the company's website athttp://investor.genomichealth.com. Please connect to the web site at least 15minutes prior to the call to allow for any software download that may benecessary.
About Genomic Health
Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused onthe development and commercialization of genomic-based clinical laboratoryservices for cancer that allow physicians and patients to make individualizedtreatment decisions. In 2004, Genomic Health launched its first test service,Oncotype DX(R), which has been shown to predict the likelihood of breastcancer recurrence and the likelihood of chemotherapy benefit in a largeportion of early-stage breast cancer patients. The company was founded in 2000and is located in Redwood City, California. For more information, please visithttp://www.genomichealth.com.
NOTE: Genomic Health, the Genomic Health logo, Oncotype, Oncotype DX andRecurrence Score are trademarks or registered trademarks of Genomic Health,Inc. All other trademarks and service marks are the property of theirrespective owners.Contacts: Brad Cole Genomic Health, Inc. 650-569-2281 [email protected] Media: Emily Faucette Genomic Health 650-569-2824 [email protected]
SOURCE Genomic Health, Inc.
